Physician profile
Samuel S Oh
NPI 1760466197
$1,778.06
in general payments reported to CMS, 2019-2025
18 companies · $544 in 2025
The $544 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.38 · 2020: $37.60 · 2022: $202 · 2023: $625 · 2024: $284 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,453.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $502.95 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $248.91 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $156.99 | 2023-2025 | Freestyle Libre 3 |
| Amgen INC. | $147.42 | 2022-2025 | Otezla, Repatha, Repatha |
| Abbvie INC. | $137.86 | 2023 | |
| Lilly USA, LLC | $122.49 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $90.25 | 2022-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Biogen, INC. | $88.77 | 2022 | |
| Hologic Sales and Service, LLC | $55.86 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Mayne Pharma Commercial LLC | $36.73 | 2025 | |
| Merck Sharp & Dohme LLC | $33.89 | 2019-2025 | Capvaxive, Enflonsia, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $27.62 | 2023 | |
| Azurity Pharmaceuticals, INC. | $24.56 | 2024 | |
| Pfizer INC. | $23.47 | 2025 | |
| Exeltis, USA INC. | $22.14 | 2025 | Slynd |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $21.52 | 2019 | |
| Dynavax Technologies Corporation | $18.35 | 2023 | Heplisav-B |
| Exact Sciences Corporation | $18.28 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.